Revolution Medici…
USUSDRevolution Medicines, Inc. (US:RVMD) — Biotechnology: Biological Products (No Diagnostic Substances). Nombre de places boursières sur lesquelles les actions de la société sont cotées : 1. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.
À propos de l'entreprise
- Site web
- revmed.com
- Relations avec les investisseurs
- revmed.com/investors/
- Secteur
- Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
- Siège social
- REDWOOD CITY, United States
- PDG
- Dr. Mark A. Goldsmith M.D., Ph.D.
- Employés
- 883
- Fondée
- 2014
- Actions en circulation
- 214.34 M au 2026-07-31
- Flottant
- 184.5 M
- Capitalisation boursière
- 43.24 Md USD
- Initiés
- 1.85%
- Investisseurs institutionnels
- 101.01%
- Secteur d'activité (SIC)
- Biological Products, (No Diagnostic Substances)
- ISIN
- US76155X1000
- LEI
- 549300JU3X0LBCQ65892
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Bourses et tickers
| Bourse | Ticker | Devise | Prix | Type |
|---|---|---|---|---|
| US USA Stocks | RVMD | USD | 199.87 -3.76% | actions ordinaires |
Dividendes
Aucun versement de dividendes n'a été trouvé (vérifié le 07.10.2026). L'entreprise ne verse probablement pas de dividendes.
Actualités de cette semaine
Pas encore d'actualités du site de l'entreprise.
Principaux actionnaires
| Détenteur | Participation | Actions | Date du rapport |
|---|---|---|---|
| Blackrock Inc. | 6.39% | 13.7 M | 2026-06-30 |
| Farallon Capital Managem… | 6.32% | 13.55 M | 2026-06-30 |
| FMR, LLC | 5.69% | 12.2 M | 2026-06-30 |
| Baker Bros. Advisors, LP | 5.34% | 11.44 M | 2026-06-30 |
| Jupiter Topco LLC | 5.01% | 10.74 M | 2026-06-30 |
| Darwin Global Management… | 4.96% | 10.63 M | 2026-06-30 |
| Vanguard Capital Managem… | 4.24% | 9.09 M | 2026-06-30 |
| Vanguard Portfolio Manag… | 3.87% | 8.29 M | 2026-06-30 |
| Nextech Invest, Ltd. | 3.55% | 7.6 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.99% | 6.41 M | 2026-06-30 |
| Paradigm Biocapital Advi… | 2.97% | 6.36 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.16% | 4.63 M | 2026-06-30 |
| Growth Fund of America | 1.38% | 2.96 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.25% | 2.67 M | 2026-06-30 |
| Fidelity Mt. Vernon Stre… | 1.15% | 2.47 M | 2026-07-31 |
| BORISY ALEXIS (Director) | ≈1.09% | 2.34 M | 2026-06-18 |
| VANGUARD INDEX FUNDS-Van… | 1.07% | 2.29 M | 2026-06-30 |
| VANGUARD SPECIALIZED FUN… | 0.86% | 1.84 M | 2026-04-30 |
| iShares Trust-iShares Bi… | 0.65% | 1.39 M | 2026-07-31 |
| JPMorgan Trust II-JPMorg… | 0.54% | 1.17 M | 2026-06-30 |
| iShares Trust-iShares Ru… | 0.51% | 1.1 M | 2026-07-31 |
| GOLDSMITH MARK A (Chief… | ≈0.46% | 984 238 | 2026-08-21 |
| KELSEY STEPHEN MICHAEL (… | ≈0.14% | 291 876 | 2026-09-11 |
| HORN MARGARET A (Chief O… | ≈0.07% | 154 647 | 2026-06-17 |
| ANDERS JACK LEE (Chief F… | ≈0.06% | 123 269 | 2026-06-24 |
| WANG XIAOLIN (Officer) | ≈0.05% | 116 063 | 2026-03-17 |
| LIN WEI (Officer) | ≈0.05% | 101 366 | 2026-03-17 |
| HORNING SANDRA (Director… | ≈0.05% | 97 765 | 2026-06-18 |
| CISLINI JEFFREY TODD (Ge… | ≈0.03% | 55 907 | 2026-08-21 |
| SCHROEDER THILO (Directo… | — | — | 2024-12-05 |
